Cart
sales@molnova.com
Dipotassium tetrachloroplatinate
CAS No. 10025-99-7
Dipotassium tetrachloroplatinate( —— )
Catalog No. M37052 CAS No. 10025-99-7
Dipotassium tetrachloroplatinate (Potassium tetrachloroplatinate) exhibits antitumor activity in solid tumor lines and can be used in the treatment of oncological diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 26 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDipotassium tetrachloroplatinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDipotassium tetrachloroplatinate (Potassium tetrachloroplatinate) exhibits antitumor activity in solid tumor lines and can be used in the treatment of oncological diseases.
-
DescriptionDipotassium tetrachloroplatinate (Potassium tetrachloroplatinate) exhibits antitumor activity in solid tumor lines and can be used in the treatment of oncological diseases. Dipotassium tetrachloroplatinate also acts as a radiosensitizer and enhances the killing effect of thermotherapy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10025-99-7
-
Formula Weight415.09
-
Molecular FormulaCl4K2Pt
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[Cl-][Pt+2]([Cl-])([Cl-])[Cl-].[K+].[K+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Cerdulatinib
Cerdulatinib is an novel oral dual Syk/JAK inhibitor.
-
α-Pinene
Kairomone for Rhizophagus grandis. Attractive to bark beetles.
-
Enfortumab
Enfortumab is a monoclonal antibody against Nectin-4.Enfortumab can be used to synthesize antibody-drug couplings (enfortumab vedotin) and can also be used in conjunction with platinum compounds to study uroepithelial cancers.
